Dual-Platform Evaluation of Charge-Modulated Betanin Delivery Using Cellular and Organismal Models
Betanin has potential for modulating lipid accumulation, but its biological activity depends on formulation and exposure conditions. We evaluated charge-modulated betanin liposomes in free fatty acid (FFA)-treated HepG2 cells and high-glucose-exposed Caenorhabditis elegans. Increasing DOTAP content from 0 to 30 mol% raised the zeta potential from −3.24 ± 0.12 to 31.09 ± 1.22 mV and the encapsulation efficiency from 35.21 ± 1.85% to 50.05 ± 1.70%. NBD-CL2 produced approximately 156-fold higher cell-associated fluorescence than NBD-CL0 in HepG2 cells, with higher fluorescence also observed descriptively in C. elegans. At the efficacy concentrations (25 μM betanin-equivalent in HepG2 cells and 50 μM in C. elegans), no apparent reduction in cell viability or survival was observed; pooled worm body-length measurements showed no overt change but did not support inference among independent exposure wells. In analyses accounting for experimental run, Bet-CL2 reduced Oil Red O intensity by 33.0% relative to the FFA-treated HepG2 group (n = 4 runs; Dunnett-adjusted p = 0.0061) and by 36.4% relative to the high-glucose C. elegans group (n = 3 runs; adjusted p = 0.017). These separate within-model results support attenuation of lipid accumulation in both models under the tested conditions, but do not establish cross-model statistical equivalence or superiority over free betanin or neutral liposomes. Carrier-associated fluorescence does not directly quantify betanin delivery. The dual-model approach supports complementary evaluation of carrier association and functional responses.
Authors
- Tae‐Joon Jeon (ORCID: https://orcid.org/0000-0002-4882-9040)
- Sunhee Yoon (ORCID: https://orcid.org/0000-0002-6237-4847)
- Sun Min Kim (ORCID: https://orcid.org/0000-0001-8420-637X)
- EunHye Kim
Institutions
- Inha University (KR)
Publication Details
- Journal
- Nanomaterials
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/nano16221492
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Inha University